8-hydroxyguanosine and Neoplasms

8-hydroxyguanosine has been researched along with Neoplasms* in 5 studies

Reviews

1 review(s) available for 8-hydroxyguanosine and Neoplasms

ArticleYear
Significance of error-avoiding mechanisms for oxidative DNA damage in carcinogenesis.
    Cancer science, 2007, Volume: 98, Issue:4

    Reactive oxygen species (ROS) are produced through normal cellular metabolism, and their formation is further enhanced by exposure to ionizing radiation and various chemicals. ROS attack DNA, and the resulting oxidative DNA damage is considered to contribute to aging, carcinogenesis and neurodegeneration. Among various types of oxidative DNA damage, 8-oxo-7,8-dihydroguanine (8-oxoguanine or 8-oxoG) is the most abundant, and plays significant roles in mutagenesis because of its ability to pair with adenine as well as cytosine. Enzymatic activities that may be responsible for preventing 8-oxoG-evoked mutations were identified in mammalian cells. We have focused on the following three enzymes: MTH1, OGG1 and MUTYH. MTH1 is a mammalian ortholog of Escherichia coli MutT, which hydrolyzes 8-oxo-dGTP to its monophosphate form in nucleotide pools, thereby preventing incorporation of the mutagenic substrate into DNA. OGG1, a functional counterpart of E. coli MutM, has an 8-oxoG DNA glycosylase activity. MUTYH, a mammalian ortholog of E. coli MutY, excises an adenine paired with 8-oxoG. These three enzymes are thought to prevent mutagenesis caused by 8-oxoG in mammals. To analyze the functions of mammalian MTH1 (Mth1), OGG1 (Ogg1) and MUTYH (Mutyh) in vivo, we established mutant mice for these three enzymes by targeted mutagenesis, and investigated spontaneous tumorigenesis as well as mutagenesis. Here we discuss our recent investigation of mutagenesis and carcinogenesis in these mutant mice.

    Topics: Amino Acid Sequence; Animals; Cell Transformation, Neoplastic; DNA Damage; DNA Glycosylases; Guanosine; Mice; Mice, Mutant Strains; Molecular Sequence Data; Mutagenesis; Neoplasms; Phosphoric Monoester Hydrolases; Reactive Oxygen Species

2007

Other Studies

4 other study(ies) available for 8-hydroxyguanosine and Neoplasms

ArticleYear
A fully validated bioanalytical method using an UHPLC-MS/MS system for quantification of DNA and RNA oxidative stress biomarkers.
    Analytical and bioanalytical chemistry, 2017, Volume: 409, Issue:14

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Biomarkers; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; DNA; Female; Guanosine; Humans; Limit of Detection; Male; Neoplasms; Neurodegenerative Diseases; Oxidative Stress; RNA; Solid Phase Extraction; Tandem Mass Spectrometry; Young Adult

2017
DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1.
    Cancer cell, 2010, Mar-16, Volume: 17, Issue:3

    Synthetic sickness/lethality (SSL) can be exploited to develop therapeutic strategies for cancer. Deficiencies in the tumor suppressor proteins MLH1 and MSH2 have been implicated in cancer. Here we demonstrate that deficiency in MSH2 is SSL with inhibition of the DNA polymerase POLB, whereas deficiency in MLH1 is SSL with DNA polymerase POLG inhibition. Both SSLs led to the accumulation of 8-oxoG oxidative DNA lesions. MSH2/POLB SSL caused nuclear 8-oxoG accumulation, whereas MLH1/POLG SSL led to a rise in mitochondrial 8-oxoG levels. Both SSLs were rescued by silencing the adenine glycosylase MUTYH, suggesting that lethality could be caused by the formation of lethal DNA breaks upon 8-oxoG accumulation. These data suggest targeted, mechanism-based therapeutic approaches.

    Topics: Adaptor Proteins, Signal Transducing; Cell Line, Tumor; DNA Glycosylases; DNA Mismatch Repair; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Gene Silencing; Guanosine; Humans; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasms; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors

2010
Dysregulation of apoptosis by benzene metabolites and their relationships with carcinogenesis.
    Biochimica et biophysica acta, 2004, Sep-06, Volume: 1690, Issue:1

    Benzene is a widely recognized human carcinogen, the effect of which is attributed to the production of reactive oxygen species (ROS) from its metabolites. Although there have been many reports on the relationship between DNA damage induced by benzene metabolites and carcinogenesis, only a report approached the subject by examining the benzene-induced dysregulation of apoptosis. Inhibition of apoptosis, aberrantly prolonging cell survival, may contribute to cancer by facilitating the insurgence of mutations and by creating a permissive environment for genetic instability. In this study, we examined the mechanism of antiapoptotic effects by benzene metabolites, p-benzoquinone (BQ) and hydroquinone (HQ), and their relationships with carcinogenesis. BQ and HQ inhibited the apoptotic death of NIH3T3 cells induced by both serum starvation and lack of an extracellular matrix (ECM). An antioxidant agent, N-acetylcysteine, significantly inhibited the antiapoptotic effects induced by benzene metabolites, indicating that the effects were mainly due to the production of ROS. Furthermore, BQ and HQ inhibited the in vitro caspase-3 activation, suggesting that the inhibition of caspase-3 activation due to ROS produced by BQ- and HQ-treatment was related to the suppression of apoptosis. The cells that escaped apoptosis could survive with the addition of serum and attachment to the ECM. Levels of 8-oxo-7,8-dihydro-2'-deoxyguanosine were higher in the cells which survived after BQ- and HQ-treatment than in the normal cells. Furthermore, the cells treated with BQ and HQ showed greater proliferation than normal cells under low-serum conditions and anchorage-independent growth in soft agar. These findings suggested that benzene metabolites induced dysregulation of apoptosis due to caspase-3 inhibition, which contributes to carcinogenesis.

    Topics: Acetylcysteine; Animals; Apoptosis; Benzene; Benzoquinones; Caspase 3; Caspases; Cell Division; Enzyme Activation; Guanosine; Hydroquinones; Mice; Neoplasms; NIH 3T3 Cells; Reactive Oxygen Species

2004
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression.
    Nature, 2003, Jul-31, Volume: 424, Issue:6948

    Reactive oxygen species are involved in many cellular metabolic and signalling processes and are thought to have a role in disease, particularly in carcinogenesis and ageing. We have generated mice with targeted inactivation of Prdx1, a member of the peroxiredoxin family of antioxidant enzymes. Here we show that mice lacking Prdx1 are viable and fertile but have a shortened lifespan owing to the development beginning at about 9 months of severe haemolytic anaemia and several malignant cancers, both of which are also observed at increased frequency in heterozygotes. The haemolytic anaemia is characterized by an increase in erythrocyte reactive oxygen species, leading to protein oxidation, haemoglobin instability, Heinz body formation and decreased erythrocyte lifespan. The malignancies include lymphomas, sarcomas and carcinomas, and are frequently associated with loss of Prdx1 expression in heterozygotes, which suggests that this protein functions as a tumour suppressor. Prdx1-deficient fibroblasts show decreased proliferation and increased sensitivity to oxidative DNA damage, whereas Prdx1-null mice have abnormalities in numbers, phenotype and function of natural killer cells. Our results implicate Prdx1 as an important defence against oxidants in ageing mice.

    Topics: Aging; Anemia, Hemolytic; Animals; Antioxidants; Cell Cycle; Cell Survival; DNA Damage; Erythrocytes; Gene Deletion; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Guanosine; Hemoglobins; Killer Cells, Natural; Longevity; Lymphoma; Mice; Neoplasms; Oxidative Stress; Peroxidases; Peroxiredoxins; Reactive Oxygen Species; Sarcoma; Survival Analysis

2003